Literature DB >> 19273186

Ovarian cancer: pathology, biology, and disease models.

Daniel G Rosen1, Gong Yang, Guangzhi Liu, Imelda Mercado-Uribe, Bin Chang, Xue Sherry Xiao, Jingfang Zheng, Feng-Xia Xue, Jinsong Liu.   

Abstract

Epithelial ovarian cancer, which comprises several histologic types and grades, is the most lethal cancer among women in the United States. In this review, we summarize recent progress in understanding the pathology and biology of this disease and in development of models for preclinical research. Our new understanding of this disease suggests new targets for therapeutic intervention and novel markers for early detection of disease.

Entities:  

Mesh：

Year:  2009        PMID： 19273186      PMCID： PMC2858969          DOI： 10.2741/3364

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN： 2768-6698


  121 in total

Review 1.  Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

Authors:  Richard Simon; Michael D Radmacher; Kevin Dobbin; Lisa M McShane
Journal:  J Natl Cancer Inst       Date:  2003-01-01       Impact factor: 13.506

Review 2.  The biology of ovarian cancer.

Authors:  N Auersperg; M I Edelson; S C Mok; S W Johnson; T C Hamilton
Journal:  Semin Oncol       Date:  1998-06       Impact factor: 4.929

3.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

4.  Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer.

Authors:  T Högberg; J Carstensen; E Simonsen
Journal:  Gynecol Oncol       Date:  1993-01       Impact factor: 5.482

5.  Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer.

Authors:  N Arnold; L Hagele; L Walz; W Schempp; J Pfisterer; T Bauknecht; M Kiechle
Journal:  Genes Chromosomes Cancer       Date:  1996-05       Impact factor: 5.006

Review 6.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Authors:  M S Naylor; G W Stamp; W D Foulkes; D Eccles; F R Balkwill
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis.

Authors:  Jeffrey D Seidman; Robert J Kurman; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2003-07       Impact factor: 6.394

9.  Isolation and ultrastructure of rabbit ovarian mesothelium (surface epithelium).

Authors:  S V Nicosia; J H Johnson; E J Streibel
Journal:  Int J Gynecol Pathol       Date:  1984       Impact factor: 2.762

10.  Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells.

Authors:  G Yang; D G Rosen; J A Colacino; I Mercado-Uribe; J Liu
Journal:  Oncogene       Date:  2006-09-04       Impact factor: 9.867
View more
  39 in total

1.  Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.

Authors:  Weiwei Shan; Imelda Mercado-Uribe; Jing Zhang; Daniel Rosen; Shiwu Zhang; Jianjun Wei; Jinsong Liu
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

2.  Hedgehog signaling pathway and ovarian cancer.

Authors:  Qi Chen; Guolan Gao; Shiwen Luo
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

3.  Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.

Authors:  Wei Dai; Jens M Teodoridis; Constanze Zeller; Janet Graham; Jenny Hersey; James M Flanagan; Euan Stronach; David W Millan; Nadeem Siddiqui; Jim Paul; Robert Brown
Journal:  Clin Cancer Res       Date:  2011-04-01       Impact factor: 12.531

Review 4.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

5.  Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.

Authors:  Haydee Lara; Yuhua Wang; Adriana S Beltran; Karla Juárez-Moreno; Xinni Yuan; Sumie Kato; Andrea V Leisewitz; Mauricio Cuello Fredes; Alexei F Licea; Denise C Connolly; Leaf Huang; Pilar Blancafort
Journal:  J Biol Chem       Date:  2012-07-10       Impact factor: 5.157

6.  A prospective study of reproductive factors and exogenous hormone use in relation to ovarian cancer risk among Black women.

Authors:  Traci N Bethea; Julie R Palmer; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2016-12-27       Impact factor: 2.506

7.  Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinoma.

Authors:  Hanxiao Wang; Stefanie Galbán; Rong Wu; Brittany M Bowman; Amanda Witte; Katrin Vetter; Craig J Galbán; Brian D Ross; Kathleen R Cho; Alnawaz Rehemtulla
Journal:  Clin Cancer Res       Date:  2012-10-24       Impact factor: 12.531

8.  Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancer.

Authors:  Ting-Ting Jiao; Ye-Min Zhang; Lin Yao; Yuan Gao; Jian Sun; Dong-Fang Zou; Guo-Ping Wu; Dan Wang; Jun Ou; Ning Hui
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

9.  Activation of hedgehog signaling is not a frequent event in ovarian cancers.

Authors:  Ling Yang; Jing He; Shuhong Huang; Xiaoli Zhang; Yuehong Bian; Nonggao He; Hongwei Zhang; Jingwu Xie
Journal:  Mol Cancer       Date:  2009-11-27       Impact factor: 27.401

10.  Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.

Authors:  Bih-Rong Wei; Shelley B Hoover; Mark M Ross; Weidong Zhou; Francesco Meani; Jennifer B Edwards; Elizabeth I Spehalski; John I Risinger; W Gregory Alvord; Octavio A Quiñones; Claudio Belluco; Luca Martella; Elio Campagnutta; Antonella Ravaggi; Ren-Ming Dai; Paul K Goldsmith; Kevin D Woolard; Sergio Pecorelli; Lance A Liotta; Emanuel F Petricoin; R Mark Simpson
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.